DNA/RNA/Nucleic AcidsMarch 19, 20266 min read

Everything You Need to Know About Nucleotide synthesis (de novo vs salvage) for Step 1

Deep dive: definition, pathophysiology, clinical presentation, diagnosis, treatment, HY associations for Nucleotide synthesis (de novo vs salvage). Include First Aid cross-references.

Everything You Need to Know About Nucleotide Synthesis (De Novo vs Salvage) for Step 1

Nucleotide synthesis is a classic USMLE Step 1 biochemistry topic because it connects core pathways (PPP, folate cycle, amino acid metabolism) to high-yield clinical syndromes and pharmacology (antimetabolites, immunosuppressants, gout meds, chemo).

Why You Should Care (Big Picture)

Nucleotides are required for:

  • DNA/RNA synthesis (cell division, repair)
  • Energy and signaling: ATP, GTP, cAMP
  • Cofactors: NAD⁺/NADP⁺, FAD, CoA
  • Activated intermediates: UDP-glucose, CDP-choline

Two ways to make nucleotides:

  1. De novo synthesis: build from scratch
  2. Salvage pathways: recycle bases (clinically huge in brain and bone marrow)

Key Definitions (Step 1 Precision)

  • Nucleoside = base + sugar
  • Nucleotide = base + sugar + phosphate(s)
  • Purines: A, G (two-ring)
  • Pyrimidines: C, U, T (one-ring)

Mnemonic: Purines are “Pure As Gold” (A, G).

De Novo vs Salvage: The Core Contrast

De Novo Synthesis (Build New)

  • Uses small precursors to build bases.
  • Energy intensive
  • Especially active in liver (major producer)

Salvage Pathways (Recycle)

  • Reuses free bases from turnover/diet.
  • Energy-saving
  • Particularly important in tissues that prefer salvage:
    • Brain
    • Bone marrow / rapidly dividing tissues
  • Clinically relevant enzyme defects:
    • HGPRT deficiency → Lesch-Nyhan
    • ADA deficiency → SCID

PURINES (A, G)

Purine De Novo Synthesis: What’s High-Yield?

Core concept

Purine ring is built directly on a ribose scaffold (contrast with pyrimidines).

Starting substrate

  • Ribose-5-phosphate → PRPP (via PRPP synthetase)
    • Ribose-5-P comes from Pentose Phosphate Pathway (PPP).

Rate-limiting step (RLS)

  • Glutamine-PRPP amidotransferase (aka amidophosphoribosyltransferase)
    • PRPP → 5-phosphoribosylamine
    • Inhibited by IMP, AMP, GMP (feedback inhibition)

Atom sources for purine ring (high-yield table)

Purine atoms come from:

  • Glycine: contributes C and N
  • Glutamine: N donors
  • Aspartate: N donor
  • CO₂: carbon
  • N¹⁰-formyl-THF: formyl groups (two carbons)

Step 1 favorite: Purine synthesis requires folate (THF) → explains why antifolates impair DNA synthesis.

End product of de novo purine synthesis

  • IMP (inosine monophosphate) → branches to:
    • AMP (uses aspartate; requires GTP)
    • GMP (uses glutamine; requires ATP)

HY twist: AMP synthesis uses GTP; GMP synthesis uses ATP → helps balance A vs G pools.

Purine Salvage Pathways (Clinically Dominant)

HGPRT (High-yield enzyme)

  • Hypoxanthine + PRPP → IMP
  • Guanine + PRPP → GMP

Lesch-Nyhan Syndrome (HGPRT deficiency)

Pathophysiology

  • ↓ salvage of hypoxanthine/guanine → ↑ PRPP and ↑ de novo purine synthesis
  • Excess purines degraded → ↑ uric acid (hyperuricemia)

Clinical presentation (classic Step 1 vignette)

  • Self-injurious behavior (lip/finger biting)
  • Aggression / dystonia / choreoathetosis
  • Intellectual disability
  • Hyperuricemia → gout, orange “sand” crystals in diaper (uric acid)

Diagnosis

  • Elevated uric acid
  • Clinical syndrome + enzyme testing/genetics

Treatment (exam-relevant)

  • Allopurinol or febuxostat to reduce uric acid
    • (They treat hyperuricemia, not neurobehavioral symptoms)
  • Supportive/neurobehavioral care

PYRIMIDINES (C, U, T)

Pyrimidine De Novo Synthesis: What’s High-Yield?

Core concept

Pyrimidine ring is made first, then attached to PRPP (contrast with purines).

Rate-limiting step (RLS)

  • Carbamoyl phosphate synthetase II (CPS II)
    • Cytosolic enzyme (important distinction from CPS I in urea cycle)

Substrates: glutamine + CO₂ + ATP → carbamoyl phosphate (cytosol)

Key sequence to know

CPS II → carbamoyl phosphate → orotic acid → UMP → UDP → UTP → CTP

What makes thymidine (dTMP)?

  • dUMP → dTMP via thymidylate synthase
    • Requires N⁵,N¹⁰-methylene-THF (folate)

Orotic Aciduria (Classic Pyrimidine Question)

Pathophysiology

Defect in UMP synthase (enzyme that converts orotic acid → UMP), causing:

  • ↑ orotic acid
  • ↓ UMP → impaired DNA/RNA synthesis

Clinical presentation

  • Megaloblastic anemia (macrocytosis) that does NOT respond to B12/folate
  • Possible growth delay/failure to thrive

Diagnosis

  • Elevated orotic acid
  • Normal ammonia (distinguishes from urea cycle defects like OTC deficiency)

Treatment

  • Uridine supplementation (bypasses block → replenishes UMP)

CRITICAL CLINICAL CROSSOVER: Purine Degradation → Gout

Uric Acid Basics (high-yield)

Purines (adenine/guanine) degrade → xanthine → uric acid (via xanthine oxidase)

Gout associations

  • Hyperuricemia: underexcretion (most common) or overproduction (e.g., high turnover, enzyme defects)
  • Can be triggered by:
    • Alcohol, dehydration, diuretics
    • High cell turnover (tumor lysis, chemo)

Key drugs

  • Allopurinol, febuxostat: inhibit xanthine oxidase
  • Rasburicase: converts uric acid → allantoin (tumor lysis prophylaxis/treatment)
  • (Step 1 nuance: vitamin C can increase uric acid excretion; thiazides decrease excretion)

DNA-Specific High-Yield: Making Deoxyribonucleotides

Ribonucleotide reductase (very testable)

Converts NDPs → dNDPs (e.g., ADP → dADP)

  • Requires thioredoxin and NADPH
  • Inhibited by hydroxyurea

Clinical tie-in: Hydroxyurea used in some myeloproliferative disorders and sickle cell disease (increases HbF); its mechanism relates directly to blocking DNA synthesis.

Folate Cycle, B12, and DNA Synthesis (Boards Favorite)

Thymidylate synthase (dUMP → dTMP)

  • Requires N⁵,N¹⁰-methylene-THF
  • Produces DHF → must be regenerated back to THF by dihydrofolate reductase (DHFR)

Drugs that hit this pathway (HY pharm integration)

  • Methotrexate (humans): inhibits DHFR → ↓ THF → ↓ dTMP → ↓ DNA synthesis
  • Trimethoprim (bacteria): inhibits bacterial DHFR
  • Pyrimethamine (protozoa): inhibits protozoal DHFR
  • 5-fluorouracil (5-FU): inhibits thymidylate synthase (via FdUMP)

“Folate trap” (B12 deficiency connection)

  • B12 deficiency traps folate as N⁵-methyl-THF → ↓ available THF for DNA synthesis → megaloblastic anemia
  • Distinguish clinically:
    • B12 deficiency: neuro symptoms + ↑ methylmalonic acid
    • Folate deficiency: no neuro symptoms, normal methylmalonic acid

High-Yield “De Novo vs Salvage” Clinical Map

When salvage matters most

  • HGPRT deficiency → Lesch-Nyhan
  • ADA deficiency → SCID
  • Rapidly dividing cells (bone marrow), CNS reliance on salvage

When de novo matters most (and drugs exploit it)

  • Cancer/immune cells have high nucleotide demand → targeted by:
    • Methotrexate (DHFR)
    • 5-FU (thymidylate synthase)
    • Hydroxyurea (ribonucleotide reductase)

ADA Deficiency (Purine Catabolism Meets Immunology)

Pathophysiology

  • Adenosine deaminase (ADA) deficiency → accumulation of adenosine and deoxyadenosine
  • ↑ dATP inhibits ribonucleotide reductase → impaired DNA synthesis
  • Profound lymphocyte dysfunction → SCID

Clinical presentation

  • Recurrent infections (bacterial, viral, fungal, protozoal)
  • Chronic diarrhea, thrush, failure to thrive (classic immunodeficiency pattern)

Diagnosis

  • Low T cells (and often B/NK depending on form)
  • Enzyme assay/genetic testing

Treatment (Step 1 level)

  • Hematopoietic stem cell transplant (definitive)
  • Enzyme replacement (PEG-ADA) in some cases
  • Gene therapy is a known association

How to Recognize These on Vignettes (Fast Pattern Recognition)

Lesch-Nyhan

  • Boy + neurobehavioral symptoms + self-mutilation + gout/hyperuricemia

Orotic aciduria (UMP synthase deficiency)

  • Megaloblastic anemia + elevated orotic acid + normal ammonia + no response to B12/folate

OTC deficiency (common trap)

  • Elevated orotic acid with hyperammonemia (urea cycle disorder), respiratory alkalosis

ADA-SCID

  • Severe recurrent infections early in life + lymphopenia

First Aid Cross-References (High-Yield Anchors)

Use these as “where to look” links in First Aid for the USMLE Step 1:

  • Purine and pyrimidine synthesis (Biochemistry → Nucleotide metabolism)
  • Lesch-Nyhan syndrome (HGPRT deficiency) (Biochemistry → Nucleotide metabolism)
  • Orotic aciduria (Biochemistry → Nucleotide metabolism)
  • ADA deficiency (SCID) (Immunology + Biochemistry crossover)
  • Folate/B12, methotrexate, 5-FU, TMP-SMX (Biochemistry + Pharmacology integration)
  • Gout drugs (Pharmacology → Anti-inflammatory drugs / antigout agents)
  • PPP / NADPH (Biochemistry → Carbohydrate metabolism; ties to ribose-5-P and reductive biosynthesis)

High-Yield Summary (What to Memorize)

De novo vs salvage

  • Purines: built on PRPP; product IMP
  • Pyrimidines: ring made first then attached to PRPP; product UMP
  • Salvage is crucial in brain; defects cause major neuro findings (HGPRT)

Rate-limiting enzymes

  • Purines: glutamine-PRPP amidotransferase
  • Pyrimidines: CPS II (cytosol)

Big named disorders

  • Lesch-Nyhan (HGPRT): self-injury + hyperuricemia
  • Orotic aciduria (UMP synthase): megaloblastic anemia, normal ammonia, treat uridine
  • ADA deficiency: SCID, ↑ dATP inhibits ribonucleotide reductase

Drug targets to connect

  • Methotrexate/TMP/pyrimethamine: DHFR
  • 5-FU: thymidylate synthase
  • Hydroxyurea: ribonucleotide reductase
  • Allopurinol/febuxostat: xanthine oxidase
Back to all articles